Old Web
English
Sign In
Acemap
>
Paper
>
PCN40 COST EFFECTIVENESS OF RITUXIMAB PLUS CVP IN PREVIOUSLY UNTREATED INDOLENT NON-HODGKIN'S LYMPHOMA
PCN40 COST EFFECTIVENESS OF RITUXIMAB PLUS CVP IN PREVIOUSLY UNTREATED INDOLENT NON-HODGKIN'S LYMPHOMA
2006
B. Maturi
W. Tong
Marlene Gyldmark
J Creeden
Rick Aultman
Fred Jost
Keywords:
Intensive care medicine
Rituximab
Non-Hodgkin's lymphoma
Hodgkin's lymphoma
Medicine
Oncology
cost effectiveness
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI
[]